coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Wyre Integrated Network Ltd PCN, Wyre · Health Inequalities Profile

    PCN U82731 · NHS Lancashire and South Cumbria Integrated Care Board · 4 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    31,602

    Registered population

    54.7% aged 18–64

    29.3%

    Aged 65+

    ICB 20.0% · England 17.9%

    2.6%

    Ethnic minority (non-White)

    1.1% Asian · England 9.6%

    0.0%

    In IMD quintile 1

    ICB 30.6% · England 21.0%

    0

    Core20 residents (est.)

    Resident basis; registered basis 0 · see page 3

    6,859

    Hypertension register

    +7.64% in 3 yrs · England +5.60%

    319

    SMI register

    25.9% of Wyre's

    881

    COPD register

    Reviews -9.76% in 3 yrs

    Forecast to 2030

    8,530

    Hypertension patients, 2030

    +1,671 on today

    65.2%

    QRISK ≥20% on statins, 2030

    +3.03pp over 3 yrs

    7.5%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    785
    Unreviewed asthma patients and falling respiratory reviews.

    About 780 (785) of 2,371 asthma patients lack a 12-month review; asthma reviews changed -5.8% and COPD -9.8% over 2023 to 2025.

    58.6%
    Lipid therapy lags England in high-risk cohorts.

    Lipid therapy in QRISK ≥ 20% is 58.6% (England 63.6%), while statins in diabetes aged 40+ without CVD reached 67.0% (-2.6% change).

    76.1%
    Breast and cervical screening exceed national benchmarks.

    Cervical screening (ages 25-49) is 76.1% (England 66.8%) and breast screening is 75.6% (England 69.9%, +10.6% change over 2023 to 2024).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    An older population with 29.3% aged 65+ may drive local chronic care demand

    Wyre Integrated Network Ltd PCN serves 31,602 registered patients. The population is distinctly older: 29.3% (9,251 patients) are aged 65+, compared to 27.1% in Wyre, 20.0% in the ICB, and 17.9% in England. Working-age adults (18–64) comprise 54.7% (Wyre 56.2%, ICB 60.4%, England 62.7%) and children (0–17) 16.1% (Wyre 16.7%, ICB 19.6%, England 19.6%). Census estimates show 97.4% White residents (Wyre 97.5%, ICB 87.8%, England 81.1%), with a 2.6% ethnic minority share. Age figures reflect registered patients, whereas ethnicity derives from Census area residents.

    Age profile

    0–1716.1%
    18–6454.7%
    65+29.3%

    65+: ICB 20.0%, England 17.9%

    Ethnicity

    White97.4%
    Asian1.1%
    Mixed1.0%
    Black0.3%
    Other0.2%

    Older people · falls rows are Wyre local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Wyre LA)1,5062,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)82.9%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)58.6%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Wyre LA)8141,0219552024/25
    Falls deaths, all ages, per 100,000 (Wyre LA)11.518.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Average deprivation is decile 6.9 and zero registered patients live in Core20 areas

    The PCN has an average IMD decile of 6.9, reflecting lower relative deprivation than Wyre (5.5 decile), England (5.5 decile) and the ICB (5.0 decile). Core20 cohort prevalence is 0.0% (estimated count 0), compared with 15.0% in Wyre, 21.0% in England and 30.6% in the ICB. Among captured practices, Core20 prevalence is 0.0% at The Village Practice and 0.0% at Lockwood GP Surgery. Average IMD decile is 6.0 at The Village Practice and 7.4 at Lockwood GP Surgery.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Village0.0% · 0 patients
    Lockwood GP0.0% · 0 patients
    Queensway0.0% · 0 patients
    Beechwood0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    319

    SMI register

    1.05% recorded prevalence

    121

    Learning disability register

    0.40% recorded prevalence

    18

    Care homes, 526 beds

    In the PCN catchment

    10.6%

    Provide unpaid care

    Wyre, Census 2021

    The PCN records 319 severe mental illness patients (1.1%) and 121 learning disability patients (0.4% vs Wyre 0.5%, ICB 0.6%, England 0.6%). The catchment includes 18 care homes with 526 beds; borough figures show 5 rough sleepers in 2025 and a 10.6% unpaid carer rate.

    Severe mental illness: physical health checks

    Recorded SMI prevalence is 1.1% (England 1.0%). For patients on the register, 85.2% had a blood pressure check (Beechwood Surgery 70.4%) and 83.0% had BMI recorded. From 2023 to 2025, blood pressure checks fell 0.6 pp (England +4.4 pp).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    6,859

    Hypertension register

    +7.64%

    Register growth, 3 yrs

    Wyre +7.69% · England +5.60%

    −1.62pp

    BP control, under 80

    ≤140/90 · +1.64pp aged 80+

    +1,671

    More patients by 2030

    Forecast 8,530 (26.25%)

    Hypertension case-finding and control

    Hypertension recorded prevalence is 22.6% (6,859 patients), above Wyre (21.7%), NHS Lancashire and South Cumbria Integrated Care Board (17.2%) and England (15.2%), which may reflect an older demography (29.3% aged 65+) across the 31,602 registered list. For patients aged under 80 with hypertension, blood pressure control is 69.3% (England 67.8%). However, from 2023 to 2025, control fell 2.3% (or 1.6 pp), lagging England (+3.2%, +2.1 pp) and the ICB (+2.9%, +1.9 pp). Over the same period, heart failure reviews fell 6.8% to 81.5% (England +8.7%). Declines could reflect routine review capacity pressure, testable by clinic audit.

    Lipids and statins

    Patients with QRISK ≥ 20% on lipid-lowering therapy is 58.6% (England 63.6%, ICB 61.4%, Wyre 59.8%). Statin treatment for diabetes aged 40+ without CVD is 67.0% (England 73.2%), falling 2.6% from 2023 to 2025 (England +2.1%). Lower uptake could reflect recall friction, testable by clinic audit.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202678,963£1.80£1.64£1.86£142,133
    Cardiovascular (all), 2025124,973£3.71£3.38£3.33£463,650

    In 2026, 78,963 items for lipid-regulating drugs cost £1.80 per item (England £1.86, ICB £1.64, Wyre £1.45). Across 78,963 items, the PCN spends £4,738 less than at England's unit cost, and £12,634 more than at NHS Lancashire and South Cumbria Integrated Care Board's unit cost.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −5.81%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −0.54%

    Asthma prevalence, PCN 3-yr % change

    COPD prevalence is 2.9% (881 patients; England 1.9%) and asthma prevalence is 8.2% (2,371 patients; England 6.6%). From 2023 to 2025, COPD reviews fell 9.8% (England +2.8%) to 74.2%, and asthma reviews fell 5.8% (England +4.4%) to 66.9%, leaving about 780 patients unreviewed. Asthma prescribing for ages 5–19 is 2,008 items per 1,000 (England 1,488). Review declines could reflect recall pressure across large registers, testable by appointment audit.

    Cancer register and children's immunisation

    Cancer prevalence is 6.3% (1,899 patients; England 3.8%). In Q1 2025/26, 6-in-1 coverage at 12 months was 98.6% (3.6 pp above the 95.0% target). However, MMR dose 1 at 24 months was 87.9% (7.1 pp below target) and age-5 4-in-1 booster was 89.4% (5.6 pp below target). Queensway Medical Centre shows a 4.2 pp drop between age-5 MMR doses. Uptake gaps could reflect recall friction, testable by call-log audit.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months98.6%

    England 91.0%

    6-in-1 complete primary course at 24 months91.4%

    England 92.2%

    MMR dose 1 at 24 months87.9%

    England 88.3%

    MMR dose 2 at age 592.4%

    England 82.8%

    4-in-1 pre-school booster at age 589.4%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    52.4%

    Lancashire and South Cumbria ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,010

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Lancashire and South Cumbria ICBEnglandNo usable stageStaged cancers
    Breast86.0%85.4%6%1,561
    Prostate42.4%53.2%11%1,404
    Lung31.1%33.8%15%1,374
    Bowel44.2%47.0%13%1,198
    Skin cancer86.1%87.8%21%519

    In 2022, 52.4% of cancers with a known stage in NHS Lancashire and South Cumbria ICB were diagnosed at stage 1 or 2 (4,642 of 8,863 cases), trailing England (55.3%) and sitting 22.6 pp below the 75.0% national ambition. Staging coverage was 74.6% (8,863 of 11,883 registered cancers), and the early-stage share fell 1.2 pp from 2013 to 2022, requiring about 2,010 additional early diagnoses annually across the ICB. Wyre Integrated Network Ltd PCN records 1,899 cancer patients (6.3% prevalence vs England 3.8%), alongside 75.6% breast screening and 76.1% cervical screening (ages 25–49). Staging metrics reflect system performance rather than PCN delivery; sustaining robust recall and prompt investigation remains essential.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026 (provisional), Blackpool Teaching Hospitals NHS Foundation Trust achieved 67.5% on the cancer 62-day referral to treatment standard (17.5 pp below the 85.0% standard), trailing University Hospitals of Morecambe Bay NHS Foundation Trust (72.4%), NHS Lancashire and South Cumbria Integrated Care Board (73.6%), Lancashire Teaching Hospitals NHS Foundation Trust (75.0%) and England (71.2%). The 28-day faster diagnosis standard reached 71.4% (standard 75.0%), but 31-day treatment reached 98.0% against the 96.0% standard. Diagnostic 6-week waits reached 21.8% for MRI and 27.6% for non-obstetric ultrasound. These figures reflect provider performance rather than PCN pathways.

    Pathways within standard (%)BlackpoolLancashireof Morecambe BayLancashire and South Cumbria ICBEngland
    28-day faster diagnosis (75%)71.3882.9078.3978.3979.32
    31-day treatment (96%)97.9689.4395.2293.6292.50
    62-day referral to treatment (85%)67.4875.0472.3573.6271.16
    Diagnostic waits over 6 weeks (%)BlackpoolLancashireof Morecambe BayEngland
    MRI21.802.414.0421.40
    CT16.4914.9713.769.92
    Echocardiography7.5713.8510.5528.48
    Colonoscopy13.080.000.6030.83
    Gastroscopy12.470.001.4529.02
    All 15 DM01 tests26.5426.6510.4423.14
    Community services activityLancashire residentsLancashire and South Cumbria ICB
    Care contacts126,445193,720
    Referrals20,41529,855
    Patients with a contact47,32065,335

    Community services (residents of Lancashire), Jun 2026 (provisional). In Jun 2026 (provisional), Wyre residents accounted for 126,445 community service contacts across the borough, of which 72,000 involved adults aged 65 and over (56.9%). These figures describe resident activity across the borough rather than Wyre Integrated Network Ltd PCN caseloads.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone access spans 23.5 pp and overall experience spans 18.2 pp across practices

    In 2025/26, overall QOF achievement was 100.0% at Beechwood Surgery and 99.8% at Queensway Medical Centre, against England's 92.5%. For vaccination and immunisation achievement, Lockwood GP Surgery achieved 93.7%, while Beechwood Surgery achieved 100.0%, a range of 6.3 pp. At Queensway Medical Centre, vaccination personalised care adjustments reached 13.4% (England 4.2%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Village950.081.9%69.8%91.5%
    Beechwood Surgery1150.088.3%83.5%86.9%
    Lockwood GP1110.076.7%70.9%84.3%
    Queensway1020.064.8%71.8%73.3%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNWyreAssetPCNWyre
    Care homes (catchment)18 (526 beds)n/aSchools (catchment)40n/a
    Children's centres37Places of worship2983
    Libraries26Food banks (VCS)n/a1
    Day centres (VCS)n/a3Carers support groups (VCS)n/a2
    Primary schools (LA maintained)1331Primary academies36
    Special schools11

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured respiratory annual review recall

    Asthma reviews fell 5.8% from 2023 to 2025 (England +4.4%) to 66.9% of 2,371 patients (about 780 unreviewed); COPD reviews fell 9.8% (England +2.8%) to 74.2% of 881. For discussion, the PCN could run a single-template respiratory recall and review inhaler prescribing, starting at the largest-volume practices. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Pharmacist-led lipid and hypertension recall

    QRISK ≥ 20% lipid therapy is 58.6% (England 63.6%, ICB 61.4%). Diabetes 40+ statins (no CVD) fell 2.6% to 67.0% (England 73.2%); under-80 BP control fell 2.3% to 69.3%. For discussion, the PCN could deploy pharmacist-led recall and medicines review for untreated high-QRISK and above-target hypertension patients. Moderate effort to run.

    Evidence base: delivery measure for eight care processes and three treatment targets; shortfall here is what shows up later as emergency admission.

    Policy anchor: NHS Diabetes Prevention Programme and the eight care processes / three treatment targets.

    Option 3

    Practice phone access and recall audit

    Phone access spans 23.5 pp (Queensway Medical Centre 64.8% to Beechwood Surgery 88.3%). MMR1 at 24 months is 87.9% (7.1 pp below 95.0%); SMI BP checks fell 0.6 pp (Beechwood Surgery 70.4%). Low cost, quick to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Anticipatory care planning (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    SMI physical check recall (p4)Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Hypertension blood pressure recall (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Childhood immunisation recall review (p6)MMR dose 1 coverage at 24 months10YHP sickness to prevention · 95% targetPCN
    Screening recall and safety netting (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Telephony and access review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Structured respiratory annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · COPD registerCore20PLUS5 respiratoryPCN
    Option 2 · Pharmacist-led lipid and hypertension recall (p12)Patients with QRISK ≥ 20% treated with lipid lowering therapy · Patients with diabetes (40+ yrs no history of CVD) treated with a statin (denominator incl. PCAs) · Hypertension registerCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 3 · Practice phone access and recall audit (p12)GPPS easy to contact the practice by phone · MMR dose 1 coverage at 24 months · Severe mental illness registerMHIS · From Harm to HopePCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15